IRCT20200610047715N1 IRCT 2020-12-27 Rafsanjan University of Medical Sciences The effect of zinc sulfate and folic acid on endocrine indices, CRP and lipid profile in women with polycystic ovary syndrome The effect of zinc sulfate and folic acid on endocrine indices, CRP and lipid profile in women with polycystic ovary syndrome in 2017-18. 2017-12-01 anticipated 50 Complete https://irct.ir/trial/48901 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Random number table; to use a table of random numbers, the exact number of people in the community was first determined and coded in order. Then, to select sample people from the table, we randomly start from a point in the table in the direction of the row or column. The selected number is in fact the individual code of the community that is selected as the sample. We will continue to do this until a small number can be selected based on the number of sample people. After completing the sample size, the sampling work is completed, Blinding description: All drugs and placebo were prepared in exactly the same drug form and packaged and coded in dark envelopes. As a result, the patient and the researcher were unaware of the group of people. 3 Polycystic ovary syndrome. Intervention 1: Intervention group: The first group received 220 mg of zinc sulfate (containing 50 mg of zinc) daily for 8 weeks. Intervention 2: Intervention group: the second group received 5 mg of folic acid daily for 8 weeks. Intervention 3: Intervention group: the third group received 220 mg of zinc sulfate (containing 50 mg of zinc) plus 5 mg of folic acid daily for 8 weeks. Intervention 4: Control group: this group received a placebo daily for 8 weeks. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no more information